Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for LabTurbo Biotech Corporation (7725:TWSE), powered by AI.
LabTurbo Biotech Corporation is currently trading at $23.15. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for LabTurbo Biotech Corporation on Alpha Lenz.
LabTurbo Biotech Corporation's P/E ratio is 85.8.
“LabTurbo Biotech Corporation trades at a P/E of 85.8 (premium valuation) with modest ROE of 1.0%.”
Ask for details →LabTurbo Biotech Corporation is a biotechnology company specializing in the research, development, and manufacturing of fully automated precision medical genetic testing systems and reagent kits. Established in 2000 and headquartered in Taipei, Taiwan, the company provides advanced solutions for nucleic acid extraction and molecular diagnostic testing, serving hospitals and clinical laboratories across Taiwan, the United States, Europe, the Middle East, and Southeast Asia. Its core product line, including the LabTurbo AIO and QuadAIO systems, offers high-throughput, automated genetic testing designed to improve the accuracy, speed, and standardization of diagnostic workflows. LabTurbo is recognized for its innovative approach to precision diagnostics, holding numerous international patents and having received national awards for innovation and research. The company’s technology supports applications in infectious disease detection, genetic screening, and precision medicine, reflecting its pivotal role in modern healthcare diagnostics and the global expansion of molecular testing capabilities.
“LabTurbo Biotech Corporation trades at a P/E of 85.8 (premium valuation) with modest ROE of 1.0%.”
Ask for details →